Aiello Bowles EJ, Ramin C, Vo JB, Feigelson HS, Gander JC, Veiga LHS, Bodelon C, Curtis RE, Brandt C, Berrington de Gonzalez A, Gierach GL. Endocrine therapy initiation among women diagnosed with ductal carcinoma in situ from 2001-2018. Breast Cancer Res Treat. 2024 Aug 16. doi: 10.1007/s10549-024-07453-0. Online ahead of print. PubMed

Abrahão R, Brunson A, Chubak J, Wernli KJ, Nichols HB, Chao C, Ruddy KJ, Hahn EE, Li Q, Malogolowkin MH, Sauder CAM, Kushi LH, Wun T, Keegan THM. Late venous thromboembolism in survivors of adolescent and young adult cancer: A population-based study in California.  Thromb Res. 2024;235:1-7. doi: 10.1016/j.thromres.2024.01.002. Epub 2024 Jan 15.  PubMed

Abrahão R, Brunson A, Ruddy KJ, Li Q, Li J, Ryder MM, Chubak J, Nichols HB, Sauder CAM, Gray MF, Hahn EE, Wun T, Keegan THM. Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study. Br J Cancer. 2024 Feb 8. doi: 10.1038/s41416-024-02594-x. [Epub ahead of print]. PubMed

Alimena S, Lykken JM, Tiro JA, Chubak J, Haas JS, Werner C, Kobrin SC, Silver MI, Perkins RB, Feldman S. Accessibility of criteria to exit cervical cancer screening at age 65 years in the electronic health record. O G Open. 1(3):p 032, September 2024. | DOI: 10.1097/og9.0000000000000035. [Epub 19 Sept 2024]. PubMed

Allison BA, Vear K, Hoopes AJ, Maslowsky J. The perceived impact of a post-Dobbs landscape on U.S. adolescents and young adults.  Contraception. 2024 Jun 13:110513. doi: 10.1016/j.contraception.2024.110513 [Epub ahead of print] PubMed

Amorim G, Tao R, Lotspeich S, Shaw PA, Lumley T, Patel RC, Shepherd BE. Three-phase generalized raking and multiple imputation estimators to address error-prone data.  Stat Med. 2024;43(2):379-394. doi: 10.1002/sim.9967. Epub 2023 Nov 21.  PubMed

Angerhofer Richards J, Cruz M, Stewart C, Lee AK, Ryan TC, Ahmedani BK, Simon GE. Effectiveness of integrating suicide care in primary care: secondary analysis of a stepped-wedge, cluster randomized implementation trial. Ann Intern Med. 2024 Oct 1. doi: 10.7326/M24-0024. [Epub ahead of print]. PubMed

Argetsinger S, LeCates RF, Zhang F, Ross-Degnan D, Wharam JF, Arterburn DE, Fernandez A, Lewis KH. Comparison of health care costs following sleeve gastrectomy versus Roux-en-Y gastric bypass among patients with type 2 diabetes.  Obesity (Silver Spring). 2024;32(4):691-701. doi: 10.1002/oby.23997. Epub 2024 Feb 13.  PubMed

Arthur KC, Mendez Sanchez A, Montero AT, Delgado P, Rosas Ramos O, Orlich F, Desai AD. Identifying adaptations for a mindfulness program for Spanish-speaking mothers of children with chronic conditions or disabilities. Health Educ Res. 2024 Jan 23;39(1):68-83. doi: 10.1093/her/cyad043. PubMed

Babu TM, Jackson LA, El Sahly HM. Next-generation SARS-CoV-2 vaccine formulations and alternative routes of administration. J Infect Dis. 2025 Feb 4;231(1):44-48. doi: 10.1093/infdis/jiae504. PubMed

Baquero BI, Berney R, Romano EFT, Hicks O, Getch R, Hall C, Mooney SJ, Rosenberg D, Shannon KL, Saelens BE, Hoerster KD. Advancing active transportation through mobility justice and centering community. Health Equity. 2024 Oct 23;8(1):720-730. doi: 10.1089/heq.2024.0087. eCollection 2024. PubMed

Barnes DE, Balderson BH, Shulman L, Rosenberg DE, Matson TE, Mettert KD, Delaney K, King D, Adams K, Fleckenstein L, Peltz CB, Idu A, Larson EB, Yaffe K, Dublin S. The Systematic Multi-domain Alzheimer's Risk Reduction Trial (SMARRT) intervention: A personalized approach to dementia risk reduction. J Alzheimers Dis. 2024 Dec 3:13872877241296161. doi: 10.1177/13872877241296161. PubMed

Benz L, Mukherjee R, Wang R, Arterburn D, Fischer H, Lee C, Shortreed SM, Haneuse S. Adjusting for selection bias due to missing eligibility criteria in emulated target trials. Am J Epidemiol. 2024 Dec 26:kwae471. doi: 10.1093/aje/kwae471. [Epub ahead of print]. PubMed

Bhimani J, O'Connell K, Ergas IJ, Foley M, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Persaud S, Rivera DR, Roh JM, Tabatabai S, Valice E, Bowles EJA, Bandera EV, Kushi LH, Kantor ED. Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer.  JCO Clin Cancer Inform. 2024;8:e2300209. doi: 10.1200/CCI.23.00209.  PubMed

Bhimani J, O'Connell K, Ergas IJ, Foley M, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Persaud S, Rivera DR, Roh JM, Tabatabai S, Valice E, Bowles EJA, Bandera EV, Kushi LH, Kantor ED. Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019.  Breast Cancer Res. 2024;26(1):101. doi: 10.1186/s13058-024-01822-9.  PubMed

Bhimani J, O'Connell K, Persaud S, Blinder V, Burganowski RP, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Aiello Bowles EJ, Kushi LH, Kantor ED. The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system. Breast Cancer Res Treat. 2024 Aug 16. doi: 10.1007/s10549-024-07433-4. [Epub ahead of print]. PubMed

Bhimani J, O’Connell K, Persaud S, Blinder V, Burganowski R, Ergas IJ, Foley M, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Bowles EJA, Kushi LH, Kantor ED. Patient characteristics associated with intended non-guideline chemotherapy in women with stage I-IIIA breast cancer. Cancer Epidemiol Biomarkers Prev. 2024 Jul 25. doi: 10.1158/1055-9965.EPI-24-0360. Online ahead of print. PubMed

Bhimani J, O’Connell K, Persaud S, Blinder V, Burganowski R, Ergas IJ, Foley M, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Bowles EJA, Kushi LH, Kantor ED. Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancer. Int J Cancer. 2024 Jul 6. doi: 10.1002/ijc.35053. Online ahead of print. PubMed

Bi Q, Dickerman BA, Nguyen HQ, Martin ET, Gaglani M, Wernli KJ, Balasubramani GK, Flannery B, Lipsitch M, Cobey S. Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection. J Infect Dis. 2024 Apr 30:jiae220. doi: 10.1093/infdis/jiae220. [Epub ahead of print]. PubMed

Bian Z, Moodie EEM, Shortreed SM, Lambert SD, Bhatnagar S. Variable selection for individualised treatment rules with discrete outcomes.  J R Stat Soc Ser C Appl Stat. 2023 Nov 2;73(2):298-313. doi: 10.1093/jrsssc/qlad096. eCollection 2024.  PubMed